Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bladder Cancer

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 46 articles:
HTML format

Single Articles

    September 2021
  1. LAI H, Cheng X, Liu Q, Luo W, et al
    Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
    Int J Cancer. 2021 Sep 3. doi: 10.1002/ijc.33794.
    PubMed     Abstract available

    March 2021
  2. TREVISANI F, Di Marco F, Raggi D, Bettiga A, et al
    Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the pure-01 study.
    Int J Cancer. 2021 Mar 15. doi: 10.1002/ijc.33554.
    PubMed     Abstract available

    February 2021
  3. VAN DOEVEREN T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, et al
    The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
    Int J Cancer. 2021;148:981-987.
    PubMed     Abstract available

    January 2021
  4. KOUTROS S, Decker KL, Baris D, Pardo LA, et al
    Bladder Cancer Risk Associated with Family History of Cancer.
    Int J Cancer. 2021 Jan 27. doi: 10.1002/ijc.33486.
    PubMed     Abstract available

    October 2020
  5. OZGUN G, Senturk S, Erkek-Ozhan S
    Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33374.
    PubMed     Abstract available

  6. WIECZOREK E, Garstka MA
    Recurrent Bladder Cancer in Aging Societies: Importance of Major Histocompatibility Complex Class I Antigen Presentation.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33359.
    PubMed     Abstract available

    July 2020
  7. ZHOU Q, Zhang H, Wang Z, Zeng H, et al
    Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
    Int J Cancer. 2020 Jul 31. doi: 10.1002/ijc.33237.
    PubMed     Abstract available

    June 2020
  8. DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
    Adherence to a Western dietary pattern and risk of bladder cancer: a pooled analysis of 13 Cohort Studies of the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Study.
    Int J Cancer. 2020 Jun 24. doi: 10.1002/ijc.33173.
    PubMed     Abstract available

  9. XU T, Li HT, Wei J, Li M, et al
    Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype.
    Int J Cancer. 2020;146:3065-3076.
    PubMed     Abstract available

    May 2020
  10. LI Y, Hendryx MS, Xun P, He K, et al
    Physical activity and risk of bladder cancer among postmenopausal women.
    Int J Cancer. 2020 May 10. doi: 10.1002/ijc.33042.
    PubMed     Abstract available

  11. SJODAHL G, Eriksson P, Patschan O, Marzouka NA, et al
    Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.
    Int J Cancer. 2020;146:2636-2647.
    PubMed     Abstract available

    April 2020
  12. HIEN TT, Ambite I, Butler D, Wan MLY, et al
    Bladder cancer therapy without toxicity - A dose-escalation study of alpha1-oleate.
    Int J Cancer. 2020 Apr 22. doi: 10.1002/ijc.33019.
    PubMed     Abstract available

  13. JOCHEMS SHJ, Reulen RC, van Osch FHM, Witlox WJA, et al
    Fruit consumption and the risk of bladder cancer: a pooled analysis by the BLadder cancer Epidemiology and Nutritional Determinants study.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33008.
    PubMed     Abstract available

    December 2019
  14. POTTEGARD A, Kristensen KB, Friis S, Hallas J, et al
    Urinary tract infections and risk of squamous cell carcinoma bladder cancer: A Danish nationwide case-control study.
    Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32842.
    PubMed     Abstract available

    November 2019
  15. VRIELING A, Bueno-De-Mesquita HB, Ros MM, Kampman E, et al
    One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
    Int J Cancer. 2019;145:2349-2359.
    PubMed     Abstract available

    October 2019
  16. ZENG H, Liu Z, Wang Z, Zhou Q, et al
    Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
    PubMed     Abstract available

  17. JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
    A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
    PubMed     Abstract available

    August 2019
  18. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Reply to: Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32632.

  19. KAWADA T
    Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32633.

    July 2019
  20. STROGGILOS R, Mokou M, Latosinska A, Makridakis M, et al
    Proteome-based classification of Non-Muscle Invasive Bladder Cancer.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32556.
    PubMed     Abstract available

    June 2019
  21. NAMEKAWA T, Ikeda K, Horie-Inoue K, Suzuki T, et al
    ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Int J Cancer. 2019 Jun 12. doi: 10.1002/ijc.32505.
    PubMed     Abstract available

    May 2019
  22. LAAKSONEN MA, MacInnis RJ, Canfell K, Giles GG, et al
    The future burden of kidney and bladder cancers preventable by behaviour modification in Australia: a pooled cohort study.
    Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32420.
    PubMed     Abstract available

  23. ZHANG K, Dai H, Liang W, Zhang L, et al
    Fermented dairy foods intake and risk of cancer.
    Int J Cancer. 2019;144:2099-2108.
    PubMed     Abstract available

    April 2019
  24. BASSETT JK, Brinkman MT, Dugue PA, Ueland PM, et al
    Circulating concentrations of B group vitamins and urothelial cell carcinoma.
    Int J Cancer. 2019;144:1909-1917.
    PubMed     Abstract available

  25. SUN M, Zhao W, Chen Z, Li M, et al
    Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 Via Mapk Signaling Pathway.
    Int J Cancer. 2019 Apr 2. doi: 10.1002/ijc.32311.
    PubMed     Abstract available

    February 2019
  26. WU Q, Fu C, Li M, Li J, et al
    CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
    Int J Cancer. 2019;144:582-594.
    PubMed     Abstract available

    January 2019
  27. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32136.
    PubMed     Abstract available

    December 2018
  28. GE Q, Lu M, Ju L, Qian K, et al
    miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer.
    Int J Cancer. 2018 Dec 3. doi: 10.1002/ijc.32036.
    PubMed     Abstract available

    October 2018
  29. LEAO R, Lee D, Figueiredo A, Hermanns T, et al
    Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behaviour of bladder cancer.
    Int J Cancer. 2018 Oct 23. doi: 10.1002/ijc.31935.
    PubMed     Abstract available

    September 2018
  30. PIAO XM, Jeong P, Kim YH, Byun YJ, et al
    Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31849.
    PubMed     Abstract available

    August 2018
  31. HERMANS TJN, Voskuilen CS, Deelen M, Mertens LS, et al
    Superior Efficacy of Neoadjuvant Chemotherapy and Radical Cystectomy in cT3-4aN0M0 compared to cT2N0M0 Bladder Cancer.
    Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31833.

    July 2018
  32. DUGUE PA, Brinkman MT, Hodge AM, Bassett JK, et al
    Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
    Int J Cancer. 2018;143:298-306.
    PubMed     Abstract available

  33. WANG W, Yang C, Nie H, Qiu X, et al
    LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31757.
    PubMed     Abstract available

  34. KOUTROS S, Baris D, Waddell R, Freeman LEB, et al
    Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31720.
    PubMed     Abstract available

  35. LIN C, Travis RC, Appleby PN, Tipper S, et al
    Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31650.
    PubMed     Abstract available

    May 2018
  36. TELEKA S, Haggstrom C, Nagel G, Bjorge T, et al
    Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31597.
    PubMed     Abstract available

    February 2018
  37. LIU X, Cheng X, Liu X, He L, et al
    Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31323.
    PubMed     Abstract available

    January 2018
  38. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    PubMed     Abstract available

    December 2017
  39. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    PubMed     Abstract available

  40. SHI X, Zhang X, Li J, Mo L, et al
    PD-1 blockade enhances the anti-tumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31219.
    PubMed     Abstract available

  41. WESTHOFF E, Wu X, Kiemeney LA, Lerner SP, et al
    Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31214.
    PubMed     Abstract available

    September 2017
  42. RAVA M, Czachorowski MJ, Silverman D, Marquez M, et al
    Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31066.
    PubMed     Abstract available

  43. MASAOKA H, Matsuo K, Sawada N, Yamaji T, et al
    Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31028.
    PubMed     Abstract available

    July 2017
  44. BOTTERI E, Ferrari P, Roswall N, Tjonneland A, et al
    Alcohol consumption and risk of urothelial cell bladder cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30894.
    PubMed     Abstract available

    January 2017
  45. SOAVE A, Riethdorf S, Dahlem R, von Amsberg G, et al
    A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Int J Cancer. 2017;140:381-389.
    PubMed     Abstract available

    December 2016
  46. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30593.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.